SCHEMBL13890107

SCHEMBL13890107

[N-]=[N+]=NC1C(N=[N+]=[N-])[C@@H]2OC3(CCCCC3)OCC2O[C@@H]1O[C@@H]1C(N=[N+]=[N-])C[C@@H](N=[N+]=[N-])C2OC3(CCCCC3)OC21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17323702 1.00 — —
SCHEMBL19619209 1.00 — —
SCHEMBL13873340 1.00 — —
SCHEMBL16882152 1.00 — —
SCHEMBL17320695 0.91 — —
SCHEMBL19619249 0.91 — —
SCHEMBL17323421 0.91 — —
SCHEMBL13890139 0.91 — —
SCHEMBL17323725 0.91 — —
SCHEMBL13873332 0.91 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2390255-A1 Novel aminoglycosides and uses thereof in the treatment of genetic disorders Technion Research & Development Foundation Limited (IL) 2011-11-30 — — EP disclosed
US-20090093418-A1 Novel aminoglycosides and uses thereof in the treatment of genetic disorders TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) 2009-04-09 — — US disclosed
Send feedback